RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ...
This article first appeared on GuruFocus. Total Revenue: $33.7 million for Q2 2026, including $6.5 million from the Alcon collaboration. Product Sales (ex-Alcon): $27.2 million, down 19% year-over-year. LAL Unit Volume: 24,917 units, down 9% year-over-year. LAL Product Revenue: $24.5 million, representing 90% of …
Sharemaestro market context Price above Trend Line 52 weeks -8.4%